Apyx Medical Corporation (APYX) has a negative trailing P/E of -14.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -6.80%.
Criteria proven by this page:
Overall SharesGrow Score: 46/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -44.9 | 1.24 | 6.77 | 4.85 | - |
| 2017 | -40.2 | -2.81 | 9.23 | 5.23 | - |
| 2018 | 3.4 | 0.00 | 2.45 | 12.87 | - |
| 2019 | -14.6 | 0.11 | 4.04 | 10.21 | - |
| 2020 | -20.7 | 0.52 | 3.87 | 8.89 | - |
| 2021 | -29.0 | -1.13 | 8.20 | 9.07 | - |
| 2022 | -3.5 | -0.07 | 2.15 | 1.81 | - |
| 2023 | -4.8 | 0.25 | 3.40 | 1.73 | - |
| 2024 | -2.4 | -0.11 | 3.95 | 1.17 | - |
| 2025 | -13.2 | 0.22 | 10.15 | 2.79 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-0.14 | $36.63M | $-3.95M | -10.8% |
| 2017 | $-0.16 | $38.88M | $-5.06M | -13% |
| 2018 | $1.86 | $16.69M | $64.01M | 383.6% |
| 2019 | $-0.58 | $28.15M | $-19.65M | -69.8% |
| 2020 | $-0.35 | $27.71M | $-11.91M | -43% |
| 2021 | $-0.44 | $48.52M | $-15.2M | -31.3% |
| 2022 | $-0.67 | $44.51M | $-23.28M | -52.3% |
| 2023 | $-0.54 | $52.35M | $-18.71M | -35.7% |
| 2024 | $-0.66 | $48.1M | $-23.46M | -48.8% |
| 2025 | $-0.27 | $52.84M | $-11.21M | -21.2% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.32 | $-0.33 – $-0.32 | $57.85M | $57.21M – $58.48M | 3 |
| 2027 | $-0.28 | $-0.29 – $-0.28 | $63.79M | $63.09M – $64.49M | 3 |
| 2028 | $-0.33 | $-0.33 – $-0.33 | $74.8M | $73.79M – $75.81M | 1 |
